Health Condition 1: O720- Third-stage hemorrhage
Conditions
Interventions
Intervention1: Intravenous Administration of injection Carbetocin: Injection Carbetocin 100 micrograms single dose intravenous route will be administered without any other confounding factor to subjec
Sponsors
Ramaiah medical college
Eligibility
Inclusion criteria
Inclusion criteria: (1) at or beyond 28 gestational weeks; (2) 18–45 years old; (2) at least one risk factor for developing atony.
Exclusion criteria
Exclusion criteria: Participants with cardiovascular disorders, hepatic or renal disease, epilepsy, known allergies to oxytocin or carbetocin.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The aim of the study is to compare the effects of carbetocin with those of oxytocin in several dosing regimens for the prevention of uterine atony in patients undergoing full term vaginal delivery. The outcome is assessed in terms of blood loss, need for additional uterotonic agents, fall in blood pressure, side effects of the drug Carbetocin if any Timepoint: Outcome is assessed immediately after delivery and 12 hours, 24 hours after delivery. | — |
Secondary
| Measure | Time frame |
|---|---|
| This study is aimed at comparing the effects of carbetocin vs oxytocin in prevention of postpartum hemorrhage following vaginal delivery in terms of: Secondary outcomes - Fall in hb Requirement of additional uterotonic agents Adverse effects Need for blood transfusionTimepoint: Outcome is assessed immediately after delivery, 12 hours & 24 hours | — |
Countries
India
Contacts
Public ContactRevathi Mallikarjuna
Ramaiah Medical College and teaching hospital
Outcome results
None listed